Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07043686 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Cerebrolysin in Early Stroke Rehabilitation - Tertiary Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study description shortened, about 319 wordsv3
  2. Primary endpoint revised
    • Interventions: The patients in Arm 1 will be treated with cerebrolysin and standard treatment. (Drug) to Cerebrolysin treatment (Drug), Standard treatment (including neurorehabilitation) of acute ischemic stroke (Other)
    • Secondary endpoints revised (5)
    • Study description expanded, about 842 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study evaluates the effect and safety of Cerebrolysin administered during early rehabilitation in patients with moderate neurological impairment after acute ischemic stroke, conducted at the Department of Vascular Neurology and Intensive Neurological Therapy, UMC Ljubljana.
Trial Details
NCT Number NCT07043686
Lead Sponsor University Medical Centre Ljubljana
Conditions
(from sponsor)		 Ischemic Stroke, Acute, Rehabilitation Outcome, Cerebrolysin
Related terms Ischemic Stroke
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov